Collaboration RevenueSAGE's collaboration revenue for Zurzuvae came in below estimates, which raises concerns about its current performance.
Sales Performance4Q24 missed expectations on the top and bottom line, largely due to Zurzuvae channel dynamics and one-time restructuring expenses.
Strategic UncertaintySAGE decided not to accept Biogen's unsolicited takeover approach, which adds uncertainty to the company's strategic direction.